BIONDVAX PHARMACEUTICALS-ADR (BVXV) Stock Cash Flow
NASDAQ:BVXV - Nasdaq - US09073Q2049 - ADR - Currency: USD
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.57M | -4.46M | -109.19M | -87.73M | -34.55M | |||
| Depreciation Amortization | 638.37K | 2.44M | 1.65M | 260.00K | 440.00K | |||
| Change In Working Capital | -2.87M | -14.61M | -3.35M | 17.93M | 2.34M | |||
| Interest Paid | N/A | 50.00K | 130.00K | 50.00K | 70.00K | |||
| Other non cash items | 6.33M | -55.91M | 33.85M | 12.35M | 21.72M | |||
| OPERATING CASH FLOW | -6.47M | -72.54M | -77.06M | -57.19M | -10.05M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -113.66K | -6.13M | -7.43M | -23.73M | -4.51M | |||
| Other Investing Activity | 18.24K | 200.00K | 230.00K | 280.00K | 11.27M | |||
| INVESTING CASH FLOW | -95.42K | -5.94M | -7.20M | -23.45M | 6.76M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -322.49K | -1.24M | 14.76M | 84.32M | N/A | |||
| Stock Issued/Repurchased | 18.24M | 14.96M | 70.46M | 0.00 | 61.84M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 17.92M | 13.72M | 85.21M | 84.32M | 61.84M | |||
| Exchange Rate Effect | 443.29K | 1.71M | -4.37M | 830.00K | -2.87M | |||
| CHANGE IN CASH | 11.79M | -63.05M | -3.42M | 4.51M | 55.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.47M | -72.54M | -77.06M | -57.19M | -10.05M | |||
| Capital Expenditure | -113.66K | -6.13M | -7.43M | -23.73M | -4.51M | |||
| FREE CASH FLOW | -6.59M | -78.67M | -84.49M | -80.92M | -14.56M | |||
All data in USD